Filing Flows › Century Therapeutics (IPSC) › Q1 2025 › vs Q1 2024
Century Therapeutics (IPSC) Q1 2025 vs Q1 2024 (year over year)
Century Therapeutics's revenue rose $108M (128×) from $855K in Q1 2024 to $109M in Q1 2025.
Century Therapeutics, Q1 2025: revenue $109M (128× year over year), operating margin 67.9%, net earnings $76.6M, operating cash flow −$34.6M. The chart draws each line against Q1 2024, the increases inside each band.
Every line
| Line | Q1 2025 | Q1 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $109M | $855K | $108M | 128× |
| Other income, net | $2.4M | $3.2M | −$864K | -27% |
| Operating profit | $74.2M | −$31.3M | $105M | — |
| Costs & expenses | $35.0M | $32.2M | $2.8M | +9% |
| Pre-tax earnings | $76.6M | −$28.1M | $105M | — |
| Research & development | $26.6M | $23.4M | $3.2M | +13% |
| General & admin | $8.4M | $8.7M | −$335K | -4% |
| Net earnings | $76.6M | −$28.1M | $105M | — |
| Operating cash sources | $117M | $8.6M | $108M | 14× |
| Depreciation | $3.2M | $3.2M | −$5K | -0.2% |
| Share-based compensation | $2.4M | $3.2M | −$781K | -24% |
| Cash used in operations | $34.6M | $30.2M | $4.4M | +14% |
| Working capital & other | $117M | $8.6M | $108M | 14× |
Questions
How much did Century Therapeutics's revenue grow year over year in Q1 2025?
Century Therapeutics's revenue rose $108M (128×) from $855K in Q1 2024 to $109M in Q1 2025.